Qiagen
 Qiagen is a provider of sample and assay technologies for molecular diagnostics applied testing academic and pharmaceutical research. Consolidated under the Dutch holding Qiagen N.V. the company operates more than 35 offices in over 20 countries. Qiagen’s shares are listed at the technology-focused U.S. stock exchange Nasdaq (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Peer M. Schatz is the company’s Chief Executive Officer.